Effectiveness of telaprevir/boceprevir-based triple therapy for chronic hepatitis c

被引：0
|
作者：
Garcia-Queiruga, Marta [1 ]
Purificacion, Cid [1 ]
Laura Maria, Martinez-Lopez [1 ]
Marta, Leston [1 ]
Luis, Margusino [1 ]
Isabel, Martin [1 ]
机构：
[1] Complexo Hosp Univ A Coruna, La Coruna, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2015年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT038
引用
收藏
页码：280 / 281
页数：2
相关论文
共 50 条
  • [1] Factors associated with success of telaprevir-and boceprevir-based triple therapy for hepatitis C virus infection
    Kian Bichoupan
    Neeta Tandon
    Valerie Martel-Laferriere
    Neal M Patel
    David Sachs
    Michel Ng
    Emily A Schonfeld
    Alexis Pappas
    James Crismale
    Alicia Stivala
    Viktoriya Khaitova
    Donald Gardenier
    Michael Linderman
    William Olson
    Ponni V Perumalswami
    Thomas D Schiano
    Joseph A Odin
    Lawrence U Liu
    Douglas T Dieterich
    Andrea D Branch
    World Journal of Hepatology, 2017, 9 (11) : 551 - 561
  • [2] Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C
    Petta, Salvatore
    Cabibbo, Giuseppe
    Enea, Marco
    Macaluso, Fabio Salvatore
    Plaia, Antonella
    Bruno, Raffaele
    Gasbarrini, Antonio
    Bruno, Savino
    Craxi, Antonio
    Camma, Calogero
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (10) : 936 - 942
  • [3] FACTORS ASSOCIATED WITH FAILURE OF TELAPREVIR- AND BOCEPREVIR-BASED HCV TRIPLE THERAPY
    Bichoupan, K.
    Tandon, N.
    Martel-Laferriere, V
    Sachs, D.
    Ng, M.
    Schonfeld, E. A.
    Pappas, A.
    Crismale, J.
    Stivala, A.
    Khaitova, V
    Gardenier, D.
    Linderman, M.
    Olson, W.
    Perumalswami, P.
    Schiano, T. D.
    Odin, J. A.
    Liu, L. U.
    Dieterich, D. T.
    Branch, A. D.
    VALUE IN HEALTH, 2014, 17 (03) : A265 - A265
  • [4] Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study
    Verna, Elizabeth C.
    Saxena, Varun
    Burton, James R.
    O'Leary, Jacqueline G.
    Dodge, Jennifer L.
    Stravitz, Richard T.
    Levitsky, Josh
    Trotter, James F.
    Everson, Gregory T.
    Brown, Robert S., Jr.
    Terrault, Norah A.
    TRANSPLANTATION, 2015, 99 (08) : 1644 - 1651
  • [5] Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
    Saxena, V.
    Manos, M. M.
    Yee, H. S.
    Catalli, L.
    Wayne, E.
    Murphy, R. C.
    Shvachko, V. A.
    Pauly, M. P.
    Chua, J.
    Monto, A.
    Terrault, N. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1213 - 1224
  • [6] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
    Moradpour, Darius
    Muellhaupt, Beat
    SWISS MEDICAL WEEKLY, 2012, 142
  • [7] ACQUIRED SPHEROCYTIC LIKE ANEMIA COMBINED WITH INEFFECTIVE ERYTHROPOIESIS SUSTAINS ANEMIA IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION RECEIVING TELAPREVIR OR BOCEPREVIR-BASED TRIPLE THERAPY
    Lupo, F.
    Russo, R.
    Iolascon, A.
    Ieluzzi, D.
    Toniutto, P.
    Piovesan, S.
    Raffetti, E.
    Siciliano, A.
    Matte, A.
    Turrini, F.
    Donato, F.
    Alberti, A.
    Zuliani, V.
    Fattovich, G.
    De Franceschi, L.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E15 - E15
  • [8] Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
    Mehawej, Mireille
    Rostaing, Lionel
    Alric, Laurent
    Del Bello, Arnaud
    Izopet, Jacques
    Kamar, Nassim
    JOURNAL OF TRANSPLANTATION, 2015, 2015
  • [9] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    HEPATOLOGY, 2013, 58 : 1112A - 1112A
  • [10] Impact of Provider Type on Hepatitis C Outcomes With Boceprevir-based and Telaprevir-based Regimens
    Backus, Lisa I.
    Belperio, Pamela S.
    Shahoumian, Troy A.
    Mole, Larry A.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2015, 49 (04) : 329 - 335
12345